Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Prepaid Assets (2023 - 2025)

Contineum Therapeutics has reported Prepaid Assets over the past 3 years, most recently at $2.5 million for Q3 2025.

  • Quarterly results put Prepaid Assets at $2.5 million for Q3 2025, up 104.55% from a year ago — trailing twelve months through Sep 2025 was $2.5 million (up 104.55% YoY), and the annual figure for FY2024 was $1.6 million, down 35.29%.
  • Prepaid Assets for Q3 2025 was $2.5 million at Contineum Therapeutics, up from $1.4 million in the prior quarter.
  • Over the last five years, Prepaid Assets for CTNM hit a ceiling of $2.5 million in Q3 2025 and a floor of $1.2 million in Q3 2024.
  • Median Prepaid Assets over the past 3 years was $1.6 million (2024), compared with a mean of $1.8 million.
  • Biggest five-year swings in Prepaid Assets: plummeted 35.29% in 2024 and later surged 104.55% in 2025.
  • Contineum Therapeutics' Prepaid Assets stood at $2.5 million in 2023, then crashed by 35.29% to $1.6 million in 2024, then soared by 54.79% to $2.5 million in 2025.
  • The last three reported values for Prepaid Assets were $2.5 million (Q3 2025), $1.4 million (Q2 2025), and $1.4 million (Q1 2025) per Business Quant data.